Qk027 Recombinant human FGF2 protein (154 aa) is a highly bioactive, long–form variant of human fibroblast growth factor 2 protein. Our recombinant FGF2 protein has been optimized for high-purity expression in E. coli, making it a reliable option for the regulation of ESC maintenance, as well as iPSC/MSC proliferation and differentiation.
Recombinant human FGF2 protein (154 aa)
£100.00 – £600.00
Recombinant human bFGF / FGF-2 protein is used to support the maintenance of human embryonic stem cells and proliferation and differentiation of induced pluripotent and mesenchymal stem cells. This 154aa form of FGF2 comprises the core structured region and N-terminal extension and is highly bioactive.
Summary: Qk027 mature domain of human FGF2 protein comprising longer structured 154 aa region (residues 135-288, Uniprot: P09038) expressed in E. coli and purified to homogeneity
Form: Protein is provided frozen in PBS (carrier protein-free) at 1 mg/ml. Animal-free.
Molecular mass: ~17 kDa
Basic fibroblast growth factor, bFGF, FGF-β, FGF2, Fibroblast growth factor-basic, HBGF-2
1. Ludwig, T. E. et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185–187 (2006).
2. Ludwig, T. E. et al. Feeder-independent culture of human embryonic stem cells. Nat. Methods 3, 637–646 (2006).
3. Chen, G., Gulbranson, D. R., Yu, P., Hou, Z. & Thomson, J. A. Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells. Stem Cells 30, 623–30 (2012).
Purity and bioactivity
For peace of mind that our recombinant human basic FGF / FGF-2 protein will work exactly the same way every day, from batch to batch and at any scale you need, we conduct extensive purity and bioactivity analysis, including SDS-PAGE, mass spectrometry, reversed-phase chromatography, UV spectroscopy and endotoxin level testing.
To confirm the biochemical identity of our bFGF / FGF-2 protein and ensure that its purity meets our rigorous standards, we conduct SDS-PAGE on every protein batch in both reduced and non-reduced conditions and use appropriate loading and high sensitivity stains.
We confirm consistent bioactivity using an FGF-responsive firefly luciferase reporter assay in HEK293T cells. By knowing what the expected activity of the protein is and measuring calibrant alongside each batch of protein, we can use this bioassay to define a complete dose-response curve and check the EC50 value of the preparation.
Find out more about our extensive purity testing in the next tab.
Example data
Protein purity: SDS-PAGE in reduced and non-reduced conditions
Bioactivity: FGF-responsive luciferase reporter assay
Research applications
iPSC/ESC maintenance
iPSC/ESC differentiation
All our proteins are produced in our Cambridge, UK labs. We provide detailed quality data for each batch because we believe reliable, high quality cytokines and growth factors are critical for successful stem cell and organoid culture. Please contact us with questions any time by email at support@qkine.com or phone +44 (0) 1223 491486 / US toll free 1-866 877 2185.
Order online and upload your PO or pay by credit card, or email your PO to orders@qkine.com.
We provide bulk orders and stock reservation for sensitive applications, please email us.
Our products are for research use only and not for diagnostic or therapeutic use. Products are not for resale.
For final purity and activity tests on our proteins, we choose a vial at random and reconstitute as recommended. Biochemical identity and purity is determined using SDS-PAGE, mass spectrometry and analytical reversed-phase chromatography. Bioactivity is quantified using an appropriate cell-based assay. As stem cells are sensitive to endotoxin levels, we use a high resolution test to ensure endotoxin levels are at industry-leading low levels (<0.01 EU per µg protein). We also check that the correct amount of protein is recovered from the vial – it might sound basic but if you order 100 µg, we believe you should receive 100 µg, so when you use the proteins you can rely on your calculated dilution.
Purity: SDS-PAGE
Result: FGF2 migrates as major band at 17 kDa in non-reducing (-βME) conditions and upon reduction (+βME).
Purified recombinant protein (7 µg) was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptothanol, R) and non-reduced conditions (NR) and stained with Coomassie Brilliant Blue R250.
Bioactivity: luciferase reporter assay
Result: FGF2 activity is determined using the Promega serum response element luciferase reporter assay (*) in transfected HEK293T cells. EC50 = 0.2 ng/ml.
Cells are treated in duplicate with a serial dilution of FGF2 for 6 hours. Firefly luciferase activity is measured and normalized to the control Renilla luciferase activity. Data are from Qk027 batch #010
*Promega pGL4.33[luc2P/SRE/Hygro] #E1340
Purity: mass spec analysis
Result: calculated molecular mass of FGF2 is 17222 Da. Molecular mass from this analysis is 17222.5 Da, consistent with the calculated mass.
MALDI mass spectrometric analysis is used to confirm the molecular mass of the intact protein and to reveal any heterogeneity that would not be evident in SDS-PAGE analysis. The results are compared with calculated mass of the protein with the assumption that all the cysteines are disulfide-linked. The different peaks represent different charge states of the protein.
Purity: endotoxin level determination
Result: Endotoxin level <0.005 EU/ug protein (below level of detection)
Stem cell cultures are sensitive to endotoxins1, which can be present in media, serum and as a contaminant on plasticware. We optimize our protein production processes to ensure the lowest possible levels of endotoxin contamination. Our endotoxin pass criteria are set at the industry-leading <0.1 EU per ug protein and we aim for <0.01 EU per ug protein. Endotoxin levels in our proteins are determined by an external expert microbiological testing services provider.
1. A biological study establishing the endotoxin limit for in vitro proliferation of human mesenchymal stem cells (2017). Yusuke Nomura, Chie Fukui, Yuki Morishita, Yuji Haishima. Regenerative Therapy, 7, 45-51.
Thaw the sample on ice, spin briefly and dilute with PBS as needed. Our proteins are supplied carrier protein-free. If compatible with your work, add carrier protein of your choice such as BSA, HSA or gelatin to further minimize loss by adsorption. Spin in a microfuge for 5 minutes at maximum speed, divide the solution into suitable aliquots and store at -80°C. We recommend that single-use aliquots should be prepared to avoid freeze-thaw cycles.
Every effort is made to ensure samples are sterile however we recommend sterile filtering after dilution in media or the final working solution.
We check that the correct amount of protein is recovered from the vial – it might sound basic but if you order 100 µg, we believe you should receive 100 µg, so when you use the proteins you can rely on your calculated dilution.
Recovery: protein quantitation
Result: UV spectrum shows full recovery of protein following aliquoting and lyophilization.
Absorbance at 280 nm: average 0.119
Recovered concentration:0.9 cm-1 x 10 /0.93 cm-1 mg ml-1 = 0.96 mg / ml
Recovery: 96%
The sample was diluted 1:10 in 100 mM sodium phosphate pH 7.4 and the UV spectrum 340-220 nm measured in duplicate. Concentration was calculated using extinction coefficient at 280 nm
